Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elena Fineberg

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Stem Cell Reports|March 27, 2018
A Critical Role of TET1/2 Proteins in Cell-Cycle Progression of Trophoblast Stem CellsStephanie Chrysanthou, Claire E Senner, Laura Woods, et al.
Developmental Cell|January 27, 2016
Maternal DNA Methylation Regulates Early Trophoblast DevelopmentMiguel R Branco, Michelle King, Vicente Perez-Garcia, et al.
Brain : a Journal of Neurology|June 11, 2010
SNARE protein redistribution and synaptic failure in a transgenic mouse model of Parkinson's diseasePablo Garcia-Reitböck, Oleg Anichtchik, Arianna Bellucci, et al.
Plos One|December 20, 2018
Identification of molecular genetic contributants to canine cutaneous mast cell tumour metastasis by global gene expression analysisKelly Bowlt Blacklock, Zeynep Birand, Deborah Biasoli, et al.
Plos Genetics|March 23, 2019
A synonymous germline variant in a gene encoding a cell adhesion molecule is associated with cutaneous mast cell tumour development in Labrador and Golden RetrieversDeborah Biasoli, Lara Compston-Garnett, Sally L Ricketts, et al.
Nature|March 15, 2018
Placentation defects are highly prevalent in embryonic lethal mouse mutantsVicente Perez-Garcia, Elena Fineberg, Robert Wilson, et al.
Journal of the National Cancer Institute|May 1, 2013
Cancer risks for BRCA1 and BRCA2 mutation carriers: results from prospective analysis of EMBRACENasim Mavaddat, Susan Peock, Debra Frost, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 20, 2014
Lymphocyte telomere length is long in BRCA1 and BRCA2 mutation carriers regardless of cancer-affected statusKaren A Pooley, Lesley McGuffog, Daniel Barrowdale, et al.
Plos Genetics|April 2, 2013
Identification of a BRCA2-specific modifier locus at 6p24 related to breast cancer riskMia M Gaudet, Karoline B Kuchenbaecker, Joseph Vijai, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 26, 2012
A nonsynonymous polymorphism in IRS1 modifies risk of developing breast and ovarian cancers in BRCA1 and ovarian cancer in BRCA2 mutation carriersYuan C Ding, Lesley McGuffog, Sue Healey, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Stem Cell Reports|March 27, 2018
A Critical Role of TET1/2 Proteins in Cell-Cycle Progression of Trophoblast Stem CellsStephanie Chrysanthou, Claire E Senner, Laura Woods, et al.
Developmental Cell|January 27, 2016
Maternal DNA Methylation Regulates Early Trophoblast DevelopmentMiguel R Branco, Michelle King, Vicente Perez-Garcia, et al.
Brain : a Journal of Neurology|June 11, 2010
SNARE protein redistribution and synaptic failure in a transgenic mouse model of Parkinson's diseasePablo Garcia-Reitböck, Oleg Anichtchik, Arianna Bellucci, et al.
Plos One|December 20, 2018
Identification of molecular genetic contributants to canine cutaneous mast cell tumour metastasis by global gene expression analysisKelly Bowlt Blacklock, Zeynep Birand, Deborah Biasoli, et al.
Plos Genetics|March 23, 2019
A synonymous germline variant in a gene encoding a cell adhesion molecule is associated with cutaneous mast cell tumour development in Labrador and Golden RetrieversDeborah Biasoli, Lara Compston-Garnett, Sally L Ricketts, et al.
Nature|March 15, 2018
Placentation defects are highly prevalent in embryonic lethal mouse mutantsVicente Perez-Garcia, Elena Fineberg, Robert Wilson, et al.
Journal of the National Cancer Institute|May 1, 2013
Cancer risks for BRCA1 and BRCA2 mutation carriers: results from prospective analysis of EMBRACENasim Mavaddat, Susan Peock, Debra Frost, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 20, 2014
Lymphocyte telomere length is long in BRCA1 and BRCA2 mutation carriers regardless of cancer-affected statusKaren A Pooley, Lesley McGuffog, Daniel Barrowdale, et al.
Plos Genetics|April 2, 2013
Identification of a BRCA2-specific modifier locus at 6p24 related to breast cancer riskMia M Gaudet, Karoline B Kuchenbaecker, Joseph Vijai, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 26, 2012
A nonsynonymous polymorphism in IRS1 modifies risk of developing breast and ovarian cancers in BRCA1 and ovarian cancer in BRCA2 mutation carriersYuan C Ding, Lesley McGuffog, Sue Healey, et al.
Pageof 2